-+ 0.00%
-+ 0.00%
-+ 0.00%

ELION THERAPEUTICS EXPANDS PIPELINE WITH EXCLUSIVE GLOBAL LICENSE TO INHALED ANTIFUNGAL FOR IMMUNOCOMPROMISED PATIENTS

Reuters·10/14/2026 11:01:24

Please log in to view news